Hence, PRK3 may function as an effector of another branch of the PI3′K oncogenic signalling network in prostate cancer, which is potentially independent of the TXA2-TPα/TPβ signalling axis [43, 44]. The gene discussed is PLAT; the disease is prostate carcinoma.